Abstract: The system can include: a vehicle 100 and a stabilizer 200. However, the system can additionally or alternatively include any other suitable set of components. The system functions to facilitate vehicular transport (e.g., via a cabin). Additionally, the system can provide impact attenuation and/or mitigate rebound of the vehicle during a water landing. Additionally or alternatively, the system can function to provide aquatic stabilization of the vehicle and/or cabin thereof. However, the system 100 can provide any other suitable functionalities.

Abstract: This disclosure provides recombinant DNA constructs and transgenic plants having enhanced traits such as increased yield, increased nitrogen use efficiency, and enhanced drought tolerance or water use efficiency. Transgenic plants may include field crops as well as plant propagules and progeny of such transgenic plants. Methods of making and using such transgenic plants are also provided. This disclosure also provides methods of producing seed from such transgenic plants, growing such seed, and selecting progeny plants with enhanced traits. Also disclosed are transgenic plants with altered phenotypes which are useful for screening and selecting transgenic events for the desired enhanced trait.

Abstract: Embodiments include herein are directed towards a system and method for estimating glitch power associated with an emulation process is provided. Embodiments may include accessing, using a processor, information associated with an electronic design database and generating cycle accurate waveform information at each node of a netlist based upon, at least in part, a portion of the electronic design database. Embodiments may further include generating a probability-based model for a plurality of inputs associated with the netlist and determining one or more partial glitch transitions from each probability-based model. Embodiments may also include combining the one or more partial glitch transitions with the cycle accurate waveform information to obtain a glitch power estimation.

Abstract: The present disclosure provides anti-nucleolin antibodies, methods of producing anti-nucleolin antibodies, and cells producing anti-nucleolin antibodies. Also provided are methods of using anti-nucleolin antibodies in treating malignant and non-malignant diseases.

Abstract: The present disclosure provides anti-nucleolin antibodies, methods of producing anti-nucleolin antibodies, and cells producing anti-nucleolin antibodies. Also provided are methods of using anti-nucleolin antibodies in treating malignant and non-malignant diseases.

Abstract: An electronic device, method, and computer program product enable orienting a user interface on a display device to a detected orientation of a face. The display device presents the user interface in a default display orientation. An image capture device captures an image. A memory contains a display orientation application. A controller is communicatively coupled to the display device, the image capture device, and the memory. The controller executes the display orientation application to enable the electronic device to provide functionality of orienting the user interface. The image captured by the image capture device is received and a face is identified within the image. An orientation of the face is determined relative to the default display orientation of the display device. At least a portion of the user interface is presented on the display device in a second display orientation that correlates to the orientation of the face.

Abstract: A formal verification EDA application can be configured to receive a circuit design of an IC chip. The circuit design of the IC chip comprises a set of properties for the IC chip and constraints for the IC chip. The formal verification EDA application generates an array of CNF files based on the circuit design of the IC chip. Each CNF file can include a Boolean expression that characterizes a selected property of the set of properties and data fields characterizing initial states for literals in the Boolean expression and the constraints of the IC chip. The formal verification application can also be configured to output the array of CNF files to a hardware prototyping platform. The hardware prototyping platform can be configured to execute a hardware instantiated SAT solver for the Boolean expression in each CNF file in the array of CNF files.

Abstract: A heat exchanger has first and second manifold portions and an array of substantially-parallel heat-transfer tubes extending between the first and second manifold portions. Each heat-transfer tube has an outer surface and an inner surface defining a conduit. In a cross-sectional view, the outer surface of each heat-transfer tube can form a first shape that is non-circular, and the inner surface of heat-transfer tube can form a second shape different than the first shape. Alternatively or additionally, at least one of the first shape and the second shape lacks reflectional symmetry in the cross-sectional view. Methods for fabricating such heat exchangers are also provided.

Abstract: An electronic device, method, and computer program product enable orienting a user interface on a display device to a detected orientation of a face. The display device presents the user interface in a default display orientation. An image capture device captures an image. A memory contains a display orientation application. A controller is communicatively coupled to the display device, the image capture device, and the memory. The controller executes the display orientation application to enable the electronic device to provide functionality of orienting the user interface. The image captured by the image capture device is received and a face is identified within the image. An orientation of the face is determined relative to the default display orientation of the display device. At least a portion of the user interface is presented on the display device in a second display orientation that correlates to the orientation of the face.

Abstract: The present invention provides for methods of producing human monoclonal antibodies to human nucleolin, cells producing such antibodies, and the antibodies themselves. Also provided are methods of using the antibodies in diagnosing and treating malignant and non-malignant diseases wherein cells that express nucleolin on the cell surface contribute to the pathophysiology of the disease.

Abstract: The present invention provides for methods of producing human monoclonal antibodies to human nucleolin, cells producing such antibodies, and the antibodies themselves. Also provided are methods of using the antibodies in diagnosing and treating malignant and non-malignant diseases wherein cells that express nucleolin on the cell surface contribute to the pathophysiology of the disease.

Abstract: The present disclosure provides anti-nucleolin antibodies, methods of producing anti-nucleolin antibodies, and cells producing anti-nucleolin antibodies. Also provided are methods of using anti-nucleolin antibodies in treating malignant and non-malignant diseases.

Abstract: The present invention provides for methods of producing human monoclonal antibodies to human nucleolin, cells producing such antibodies, and the antibodies themselves. Also provided are methods of using the antibodies in diagnosing and treating malignant and non-malignant diseases wherein cells that express nucleolin on the cell surface contribute to the pathophysiology of the disease.

Abstract: The present invention provides for methods of producing human monoclonal antibodies to human nucleolin, cells producing such antibodies, and the antibodies themselves. Also provided are methods of using the antibodies in diagnosing and treating malignant and non-malignant diseases wherein cells that express nucleolin on the cell surface contribute to the pathophysiology of the disease.

Abstract: The present invention provides for methods of producing human monoclonal antibodies to human nucleolin, cells producing such antibodies, and the antibodies themselves. Also provided are methods of using the antibodies in diagnosing and treating malignant and non-malignant diseases wherein cells that express nucleolin on the cell surface contribute to the pathophysi-ology of the disease.